Physician profile
John Thomas
NPI 1013039841
$98,518.16
in general payments reported to CMS, 2019-2025
29 companies · $5,623 in 2025
The $5,623 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,774 · 2020: $1,615 · 2021: $338 · 2022: $9,643 · 2023: $52K · 2024: $26K · 2025: $5,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $60K · Travel and Lodging: $16K · Food and Beverage: $4,493 · Education: $1,800 · Consulting Fee: $900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $60,062.50 |
| Travel and Lodging | $16,442.47 |
| Food and Beverage | $4,492.81 |
| Education | $1,800.00 |
| Consulting Fee | $900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $89,967.93 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $2,059.53 | 2019 | |
| Medtronic, INC. | $1,399.52 | 2021-2023 | Venaseal, Corevalve Evolut R, Closurefast |
| Polarityte, INC. | $1,263.03 | 2019-2020 | |
| Vaporox, INC. | $576.56 | 2024-2025 | |
| Smith+Nephew, INC. | $572.30 | 2024-2025 | Grafix Pl, Renasys Touch, Collagenase Santyl |
| Kci USA, INC. | $358.11 | 2019-2023 | V.A.C. Dermatac, 3m Cavilon, V.A.C. Granufoam |
| Medtronic Vascular, INC. | $354.77 | 2020 | |
| Convatec INC. | $346.70 | 2023-2025 | |
| Cardiovascular Systems INC. | $217.30 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $207.69 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $197.60 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Next Science LLC | $158.81 | 2023 | Blastx, Xperience, Surgx |
| Medline Industries Lp | $144.78 | 2019 | |
| Hartmann USA, INC. | $116.94 | 2022-2023 | Zetuvit Plus |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $106.99 | 2025 | Miro3d |
| Abbott Laboratories | $102.09 | 2023 | Diamondback Peripheral |
| Reapplix INC. | $68.00 | 2021 | |
| Ethicon US, LLC | $43.37 | 2023 | Dermabond Prineo |
| Amniox Medical, INC. | $42.65 | 2020 | |
| Argon Medical Devices, INC. | $38.33 | 2021-2022 | |
| Boston Scientific Corporation | $33.86 | 2024 | Varithena Administration Pack |
| Cashflow Solutions, LLC | $30.01 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Legend Biotech USA INC. | $27.93 | 2025 | Carvykti |
| Stryker Corporation | $20.15 | 2025 | Inthrill Thrombectomy Catheter |
| Triad Life Sciences INC. | $17.09 | 2022 | |
| Hydrofera LLC | $17.00 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.25 | 2025 | Farxiga |
| Mdd US Operations, LLC | $13.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.